STXS Financials: Stereotaxis Inc AI Analysis



Financials

STXS Financial

Stereotaxis Inc

$1.86

-3.37%

$-0.06

At close: Apr 28, 16:00:00 GMT-4

$1.84

-0.8%

$-0.01

Pre-market: Apr 29, 05:20:02 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$1.92

Open

$1.94

Day's Range

$1.84 - $1.94

52 week range

$1.74 - $3.59

Volume

233.9K

Avg.Volume

491.1K

Dividend yield

EPS (TTM)

-0.24

Market Cap

$179.8M

What is STXS?

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 131 full-time employees. The company went IPO on 2004-08-12. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Features

Markets

News

Income

Balance sheet

Cash flow

Annual

Quarterly

STXS Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	06/30/2025	12/31/2024	06/30/2024	12/31/2023
Revenue	944	660	284	493	366	447
Revenue Growth (YoY)	10%	34%	-22%	10%	67%	19%
Cost of Revenue	735	514	221	387	285	346
Gross Profit	208	145	63	106	80	101
Selling, General & Admin	40	19	20	17	19	17
Research & Development	--	--	--	--	--	--
Operating Expenses	40	19	20	17	19	17
Other Non Operating Income (Expenses)	-1	-1	0	0	0	0
Pretax Income	152	115	37	80	54	75
Income Tax Expense	19	14	5	12	7	10
Net Income	132	101	31	67	46	65
Net Income Growth	16%	51%	-33%	3%	119%	23%
Shares Outstanding (Diluted)	632.61	632.61	622.96	639.95	649.39	672
Shares Change (YoY)	-1%	-1%	-4%	-5%	-5%	-4%
EPS (Diluted)	0.21	0.15	0.05	0.1	0.07	0.1
EPS Growth	18%	51%	-30%	6%	141%	30%
Free Cash Flow	67	187	-119	82	47	136
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	22.03%	21.96%	22.18%	21.5%	21.85%	22.59%
Operating Margin	17.79%	18.93%	14.78%	17.84%	16.66%	18.56%
Profit Margin	13.98%	15.3%	10.91%	13.59%	12.56%	14.54%
Free Cash Flow Margin	7.09%	28.33%	-41.9%	16.63%	12.84%	30.42%
EBITDA	170	126	42	89	61	84
EBITDA Margin	18%	19.09%	14.78%	18.05%	16.66%	18.79%
D&A For EBITDA	2	1	0	1	0	1
EBIT	168	125	42	88	61	83
EBIT Margin	17.79%	18.93%	14.78%	17.84%	16.66%	18.56%
Effective Tax Rate	12.5%	12.17%	13.51%	15%	12.96%	13.33%

Follow-Up Questions

What are Stereotaxis Inc's key financial statements?



According to the latest financial statement (Form-10K), Cairn Homes PLC has a total asset of $0, Net loss of $0

What are the key financial ratios for STXS?



Cairn Homes PLC's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Stereotaxis Inc's revenue broken down by segment or geography?



Cairn Homes PLC largest revenue segment is Apartments, at a revenue of 456,289,495 in the most earnings release.For geography, Ireland is the primary market for Cairn Homes PLC, at a revenue of 711,498,406.

Is Stereotaxis Inc profitable?



no, according to the latest financial statements, Cairn Homes PLC has a net loss of $0

Does Stereotaxis Inc have any liabilities?



no, Cairn Homes PLC has liability of 0

How many outstanding shares for Stereotaxis Inc?



Cairn Homes PLC has a total outstanding shares of 0

Stereotaxis Inc (STXS) Financial

STXS Stock Price Chart